Guardion Health Sciences, Inc. (GHSI)

Guardion Health Sciences, Inc. (GHSI) — VMCI valuation read

Headline read on GHSI: VMCI of 58/100 versus a Healthcare sector median of 50. The 8-point above-median position is what makes Guardion Health Sciences, Inc. a relative-value candidate in the mid-cap cohort, before any pillar-level review.

Form 4 filings on GHSI: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.

**Investor frame.** Three reads on GHSI: value (GHSI trades at 15.0x earnings, 17% below the Healthcare median of 18.0x), quality (ROIC of 15.0% sits 5.0pp above the Healthcare median (10.0%)), and risk (net debt to EBITDA of -1.2x leaves covenant headroom). The value read also implies an EV/EBITDA gap of +4.0x against the Healthcare 12.0x baseline.

GHSI fell 2.7% over the trailing 7 days, with a -19.2% read on a 30-day basis.